Prostaglandin E1 inhibits collagenase gene expression in rabbit synoviocytes and human fibroblasts

R Salvatori1, P T Guidon, B E Rapuano

  • 1Department of Medicine, Cornell University Medical College, New York, New York.

Endocrinology
|July 11, 1992
PubMed

Insights

Prostaglandin E1 (PGE1) reduces collagenase mRNA levels, an enzyme linked to cartilage breakdown. This effect is mediated by increased intracellular cAMP levels, offering potential therapeutic insights for joint diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Cartilage breakdown in joint diseases involves proteolytic enzymes like collagenase.
  • Collagenase gene expression is stimulated by 12-O-tetradecanoyl-phorbol-13-acetate (TPA).

Purpose of the Study:

  • To investigate the effect of prostaglandin E1 (PGE1) on TPA-stimulated collagenase mRNA levels.
  • To explore the role of intracellular cyclic AMP (cAMP) in this regulation.

Main Methods:

  • Utilized the rabbit synoviocyte cell line HIG-82 and human skin fibroblasts.
  • Measured collagenase mRNA levels following treatment with prostaglandins, forskolin, and IBMX.
  • Performed transient transfection assays with a collagenase gene promoter-luciferase construct.

Main Results:

  • PGE1 selectively reduced collagenase mRNA levels in a dose-dependent manner.
  • PGE1 increased intracellular cAMP levels, an effect mimicked by forskolin and IBMX.
  • PGE1, forskolin, and IBMX inhibited collagenase gene promoter activity.

Conclusions:

  • PGE1, via increased cAMP, inhibits collagenase gene expression at the promoter level.
  • This mechanism is conserved across different cell types, including synoviocytes and fibroblasts.
  • Findings suggest potential therapeutic strategies for managing cartilage-degrading enzymes in joint diseases.

Related Concept Videos